Sarah Cianférani
Centre National de la Recherche Scientifique · 406 works · 11,831 citations · h-index 57
Top works
- Characterization of Therapeutic Antibodies and Related Products
- Structural and Functional Evidence for Ligand-Independent Transcriptional Activation by the Estrogen-Related Receptor 3
- 2-D Structure of the A Region of Xist RNA and Its Implication for PRC2 Association
- A Sulfenic Acid Enzyme Intermediate Is Involved in the Catalytic Mechanism of Peptide Methionine Sulfoxide Reductase fromEscherichia coli
- Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
- All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ
- In Situ Characterization of Polymorphic Forms: The Potential of Raman Techniques
- Characterization of the Methionine Sulfoxide Reductase Activities of PILB, a Probable Virulence Factor from Neisseria meningitidis
- Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression
- Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma
- Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate
- Innovative Native MS Methodologies for Antibody Drug Conjugate Characterization: High Resolution Native MS and IM-MS for Average DAR and DAR Distribution Assessment
- A novel mechano‐enzymatic cleavage mechanism underlies transthyretin amyloidogenesis
- Analytical characterization of biosimilar antibodies and Fc-fusion proteins
- Proline: an efficient and user-friendly software suite for large-scale proteomics
- Cutting‐edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies
- Vapor Pressure and Heat of Sublimation of Crystal Polymorphs
- Adding a new separation dimension to MS and LC–MS: What is the utility of ion mobility spectrometry?
- Cutting‐edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies
- Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates